Skip to main content
Log in

Skleromyxödem

  • Kurzkasuistiken
  • Published:
Der Hautarzt Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1 a
Abb. 2

Literatur

  1. Donato ML, Feasel AM, Weber DM et al. (2006) Scleromyxedema: role of high-dose melphalan with autologous stem cell transplantation. Blood 107: 463–466

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Horn KB, Horn MA, Swan J et al. (2004) A complete and durable clinical response to high-dose dexamethasone in a patient with scleromyxedema. J Am Acad Dermatol 51: S120–123

    Article  PubMed  Google Scholar 

  3. Karim A, Lawlor F, Black MM (2004) Successful treatment of scleromyxoedema with high dose intravenous immunoglobulin. Clin Exp Dermatol 29: 317–318

    Article  CAS  PubMed  Google Scholar 

  4. Pomann JJ, Rudner EJ (2003) Scleromyxedema revisited. Int J Dermatol 42: 313–315

    Article  Google Scholar 

  5. Sansbury JC, Cocuroccia B, Jorizzo JL et al. (2004) Treatment of recalcitrant scleromyxedema with thalidomide in 3 patients. J Am Acad Dermatol 51: 126–131

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt

Keine Angaben

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. Reifenberger.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kukova, G., Bruch-Gerharz, D., Gensch, K. et al. Skleromyxödem. Hautarzt 57, 326–327 (2006). https://doi.org/10.1007/s00105-006-1113-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00105-006-1113-z

Navigation